🇺🇸 FDA
Patent

US 9757384

Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

granted A61KA61K31/137A61K31/155

Quick answer

US patent 9757384 (Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome) held by ESSENTIALIS, INC. expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ESSENTIALIS, INC.
Grant date
Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/137, A61K31/155, A61K31/549, A61K31/551